Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 10, Pages 2181-2197
http://dx.doi.org/10.1100/tsw.2010.213
Review Article

The Nuclear Hormone Receptor PPARγ as a Therapeutic Target in Major Diseases

Institute of Biochemistry I-Pathobiochemistry, Faculty of Medicine, Goethe-University Frankfurt, Germany

Received 29 July 2010; Revised 12 October 2010; Accepted 25 October 2010

Academic Editor: Martin Goette

Copyright © 2010 Martina Victoria Schmidt et al.

Citations to this Article [66 citations]

The following is the list of published articles that have cited the current article.

  • J. A. Zuris, Y. Harir, A. R. Conlan, M. Shvartsman, D. Michaeli, S. Tamir, M. L. Paddock, J. N. Onuchic, R. Mittler, Z. I. Cabantchik, P. A. Jennings, and R. Nechushtai, “Facile transfer of [2Fe-2S] clusters from the diabetes drug target mitoNEET to an apo-acceptor protein,” Proceedings of the National Academy of Sciences, vol. 108, no. 32, pp. 13047–13052, 2011. View at Publisher · View at Google Scholar
  • Martina Victoria Schmidt, Patrick Paulus, Anne-Marie Kuhn, Andreas Weigert, Virginie Morbitzer, Kai Zacharowski, Volkhard A. J. Kempf, Bernhard Brüne, and Andreas von Knethen, “Peroxisome Proliferator–activated Receptor γ–induced T Cell Apoptosis Reduces Survival during Polymicrobial Sepsis,” American Journal of Respiratory and Critical Care Medicine, vol. 184, no. 1, pp. 64–74, 2011. View at Publisher · View at Google Scholar
  • Virginia Motilva, Sofía García-Mauriño, Elena Talero, and Matilde Illanes, “New paradigms in chronic intestinal inflammation and colon cancer: role of melatonin,” Journal of Pineal Research, vol. 51, no. 1, pp. 44–60, 2011. View at Publisher · View at Google Scholar
  • Frank M. Faraci, “Protecting against vascular disease in brain,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 300, no. 5, pp. H1566–H1582, 2011. View at Publisher · View at Google Scholar
  • Conrad P. Hodgkinson, and Shu Ye, “Toll-Like Receptors, Their Ligands, and Atherosclerosis,” Thescientificworldjournal, vol. 11, pp. 437–453, 2011. View at Publisher · View at Google Scholar
  • David J. Eve, Cesar V. Borlongan, and Paul R. Sanberg, “A Showcase of Bench-to-Bedside Regenerative Medicine at the 2010 ASNTR,” The Scientific World JOURNAL, vol. 11, pp. 1842–1864, 2011. View at Publisher · View at Google Scholar
  • Javier Avila-Roman, Elena Talero, and Virginia Motilva, “Chemoprevention with Phytonutrients and Microalgae Products in Chronic Inflammation and Colon Cancer,” Current Pharmaceutical Design, vol. 18, no. 26, pp. 3939–3965, 2012. View at Publisher · View at Google Scholar
  • Philippe M. Campeau, Olga Astapova, Rebecca Martins, Jean Bergeron, Patrick Couture, Robert A. Hegele, Todd Leff, and Claude Gagne, “Clinical and molecular characterization of a severe form of partial lipodystrophy expanding the phenotype of PPAR gamma deficiency,” Journal Of Lipid Research, vol. 53, no. 9, pp. 1968–1978, 2012. View at Publisher · View at Google Scholar
  • Guoyue Yuan, Jue Jia, Liangliang Di, Libin Zhou, Sijing Dong, Jingjing Ye, Dong Wang, Ling Yang, Jifang Wang, Lianxi Li, Ying Yang, Chaoming Mao, and Mingdao Chen, “Effects of C-reactive protein on adipokines genes expression in 3T3-L1 adipocytes,” Biochemical and Biophysical Research Communications, vol. 424, no. 3, pp. 462–468, 2012. View at Publisher · View at Google Scholar
  • Nidhi Chaudhary, Kiran Kumar Nakka, Nilanjana Maulik, and Samit Chattopadhyay, “Epigenetic Manifestation of Metabolic Syndrome and Dietary Management,” Antioxidants & Redox Signaling, vol. 17, no. 2, pp. 254–281, 2012. View at Publisher · View at Google Scholar
  • Ye Wang, Maria M. Jacome-Sosa, Megan R. Ruth, Yan Lu, Jianheng Shen, Martin J. Reaney, Shannon L. Scott, Michael E. R. Dugan, Hope D. Anderson, Catherine J. Field, Spencer D. Proctor, and Donna F. Vine, “The intestinal bioavailability of vaccenic acid and activation of peroxisome proliferator-activated receptor-α and -γ in a rodent model of dyslipidemia and the metabolic syndrome,” Molecular Nutrition & Food Research, vol. 56, no. 8, pp. 1234–1246, 2012. View at Publisher · View at Google Scholar
  • Polina Loseva, S Kostyuk, E Malinovskaya, N Clement, Ca Dechesne, C Dani, T Smirnova, K Glebova, G Baidakova, A Baranova, V Izhevskaia, E Ginter, and N Veiko, “Extracellular DNA oxidation stimulates activation of NRF2 and reduces the production of ROS in human mesenchymal stem cells,” Expert Opinion on Biological Therapy, vol. 12, no. S1, pp. S85–S97, 2012. View at Publisher · View at Google Scholar
  • Mary L. Modrick, Dale A. Kinzenbaw, Yi Chu, Curt D. Sigmund, and Frank M. Faraci, “Peroxisome proliferator-activated receptor-gamma protects against vascular aging,” American Journal Of Physiology-Regulatory Integrative And Comparative Physi, vol. 302, no. 10, pp. R1184–R1190, 2012. View at Publisher · View at Google Scholar
  • Takuji Tanaka, Masahito Shnimizu, and Hisataka Moriwaki, “Cancer Chemoprevention by Carotenoids,” Molecules, vol. 17, no. 3, pp. 3202–3242, 2012. View at Publisher · View at Google Scholar
  • Massimiliano Cazzaniga, and Bernardo Bonanni, “Prevention of ER-negative breast cancer: where do we stand?,” European Journal of Cancer Prevention, vol. 21, no. 2, pp. 171–181, 2012. View at Publisher · View at Google Scholar
  • Lalitha Ramachandran, Duane T. Smoot, Hassan Ashktorab, Patrick Tan, Kwang Seok Ahn, Chun Wei Yap, Alan Prem Kumar, Gautam Sethi, Kanjoormana Aryan Manu, Muthu K. Shanmugam, Feng Li, Kodappully Sivaraman Siveen, Shireen Vali, Shweta Kapoor, Taher Abbasi, and Rohit Surana, “Isorhamnetin inhibits proliferation and invasion and induces apoptosis through the modulation of peroxisome proliferator-activated receptor γ activation pathway in gastric cancer,” Journal of Biological Chemistry, vol. 287, no. 45, pp. 38028–38040, 2012. View at Publisher · View at Google Scholar
  • Karen T. Liby, and Michael B. Sporn, “Synthetic oleanane triterpenoids: Multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease,” Pharmacological Reviews, vol. 64, no. 4, pp. 972–1003, 2012. View at Publisher · View at Google Scholar
  • H. Zhou, J. M. Spaeth, N. H. Kim, X. Xu, M. J. Friez, C. E. Schwartz, and T. G. Boyer, “From the Cover: MED12 mutations link intellectual disability syndromes with dysregulated GLI3-dependent Sonic Hedgehog signaling,” Proceedings of the National Academy of Sciences, vol. 109, no. 48, pp. 19763–19768, 2012. View at Publisher · View at Google Scholar
  • Alexey A. Moskalev, Zeljka Smit-McBride, Mikhail V. Shaposhnikov, Ekaterina N. Plyusnina, Alex Zhavoronkov, Arie Budovsky, Robi Tacutu, and Vadim E. Fraifeld, “Gadd45 proteins: Relevance to aging, longevity and age-related pathologies,” Ageing Research Reviews, vol. 11, no. 1, pp. 51–66, 2012. View at Publisher · View at Google Scholar
  • Jichun Yang, Yunfeng Zhou, and Youfei Guan, “PPARγ as a therapeutic target in diabetic nephropathy and other renal diseases,” Current Opinion in Nephrology and Hypertension, vol. 21, no. 1, pp. 97–105, 2012. View at Publisher · View at Google Scholar
  • Sakshi Sikka, Luxi Chen, Gautam Sethi, and Alan Prem Kumar, “Targeting PPARγ Signaling Cascade for the Prevention and Treatment of Prostate Cancer,” PPAR Research, vol. 2012, pp. 1–14, 2012. View at Publisher · View at Google Scholar
  • Zhiwei Wang, Hidefumi Fukushima, Hiroyuki Inuzuka, Lixin Wan, Pengda Liu, Daming Gao, Fazlul H. Sarkar, and Wenyi Wei, “Skp2 is a promising therapeutic target in breast cancer,” Frontiers in Oncology, vol. 1, 2012. View at Publisher · View at Google Scholar
  • Silvia Zappavigna, Michele Caraglia, Annamaria Colao, Alessandra Dicitore, Daniela Mari, Giovanni Vitale, Luca Persani, and Leo J. Hofland, “Combined Treatment with PPAR-gamma Agonists in Pancreatic Cancer: A Glimmer of Hope for Cancer Therapy?,” Current Cancer Drug Targets, vol. 13, no. 4, pp. 460–471, 2013. View at Publisher · View at Google Scholar
  • D Vara, C Morell, N Rodríguez-Henche, and I Diaz-Laviada, “Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma,” Cell Death and Disease, vol. 4, no. 5, pp. e618, 2013. View at Publisher · View at Google Scholar
  • Ana L. Alessandri, Lirlândia P. Sousa, Christopher D. Lucas, Adriano G. Rossi, Vanessa Pinho, and Mauro M. Teixeira, “Resolution of inflammation: Mechanisms and opportunity for drug development,” Pharmacology & Therapeutics, 2013. View at Publisher · View at Google Scholar
  • Daisuke Yoshihara, Masanori Kugita, Mai Sasaki, Shigeo Horie, Koichi Nakanishi, Takaaki Abe, Harold M. Aukema, Tamio Yamaguchi, and Shizuko Nagao, “Telmisartan Ameliorates Fibrocystic Liver Disease in an Orthologous Rat Model of Human Autosomal Recessive Polycystic Kidney Disease,” Plos One, vol. 8, no. 12, 2013. View at Publisher · View at Google Scholar
  • Alessandra Dicitore, Michele Caraglia, Germano Gaudenzi, Gloria Manfredi, Bruno Amato, Daniela Mari, Luca Persani, Claudio Arra, and Giovanni Vitale, “Type I Interferon-mediated pathway interacts with Peroxisome Proliferator Activated Receptor-γ (PPAR-γ): At the cross-road of pancreatic cancer cell proliferation,” Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2013. View at Publisher · View at Google Scholar
  • M Keuper, I Wernstedt Asterholm, P E Scherer, M-A Westhoff, P Möller, K-M Debatin, G Strauss, M Wabitsch, and P Fischer-Posovszky, “TRAIL (TNF-related apoptosis-inducing ligand) regulates adipocyte metabolism by caspase-mediated cleavage of PPARgamma,” Cell Death and Disease, vol. 4, no. 1, pp. e474, 2013. View at Publisher · View at Google Scholar
  • M. S. Herrera-Meza, M. R. Mendoza-López, O. García-Barradas, M. G. Sanchez-Otero, E. R. Silva-Hernández, J. O. Angulo, and R. M. Oliart-Ros, “Dietary anhydrous milk fat naturally enriched with conjugated linoleic acid and vaccenic acid modify cardiovascular risk biomarkers in spontaneously hypertensive rats,” International Journal of Food Sciences and Nutrition, pp. 130130051521004, 2013. View at Publisher · View at Google Scholar
  • Laurindo Ferreira da Rocha Junior, Moacyr Jesus Barreto de Melo Rêgo, Mariana Brayner Cavalcanti, Michelly Cristiny Pereira, Marina Galdino da Rocha Pitta, Priscilla Stela Santana de Oliveira, Sayonara Maria Calado Gonçalves, Angela Luzia Branco Pinto Duarte, Maria do Carmo Alves de Lima, Ivan da Rocha Pitta, and Maira Galdino da Rocha Pitta, “Synthesis of a Novel Thiazolidinedione and Evaluation of Its Modulatory Effect on IFN-γ, IL-6, IL-17A, and IL-22 Production in PBMCs from Rheumatoid Arthritis Patients,” BioMed Research International, vol. 2013, pp. 1–8, 2013. View at Publisher · View at Google Scholar
  • Tran Le, Ming Tong, VanAnh Nguyen, and Suzanne M. de la Monte, “PPAR Agonist Rescue of Ethanol-Impaired Brain Insulin Signaling: Cerebellar Slice Culture Model,” Journal of Drug and Alcohol Research, vol. 2, pp. 1–9, 2013. View at Publisher · View at Google Scholar
  • Francisco A. Monsalve, Radha D. Pyarasani, Fernando Delgado-Lopez, and Rodrigo Moore-Carrasco, “Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases,” Mediators of Inflammation, vol. 2013, pp. 1–18, 2013. View at Publisher · View at Google Scholar
  • Laurindo Ferreira da Rocha Junior, Andréa Tavares Dantas, Ângela Luzia Branco Pinto Duarte, Moacyr Jesus Barreto de Melo Rego, Ivan da Rocha Pitta, and Maira Galdino da Rocha Pitta, “PPAR Agonists in Adaptive Immunity: What Do Immune Disorders and Their Models Have to Tell Us?,” PPAR Research, vol. 2013, pp. 1–9, 2013. View at Publisher · View at Google Scholar
  • Kumar Nikhil, Shruti Sharan, Abhimanyu K. Singh, Ajanta Chakraborty, and Partha Roy, “Anticancer Activities of Pterostilbene-Isothiocyanate Conjugate in Breast Cancer Cells: Involvement of PPAR gamma,” Plos One, vol. 9, no. 8, 2014. View at Publisher · View at Google Scholar
  • Nikhilesh Arya, Mangesh D. Kharjul, Chamanlal J. Shishoo, Vishnu Thakre, and Kishor S. Jain, “Some molecular targets for antihyperlipidemic drug research,” European Journal of Medicinal Chemistry, 2014. View at Publisher · View at Google Scholar
  • Jiamei Lu, Lu Liu, Yanting Zhu, Yonghong Zhang, Yuanyuan Wu, Guizuo Wang, Dexin Zhang, Jing Xu, Xinming Xie, Rui Ke, Dong Han, Shaojun Li, Wei Feng, Mei Xie, Yun Liu, Ping Fang, Hongyang Shi, Ping He, Yuan Liu, Xiuzhen Sun, and Manxiang Li, “PPAR-γ inhibits IL-13-induced collagen production in mouse airway fibroblasts,” European Journal of Pharmacology, 2014. View at Publisher · View at Google Scholar
  • Dariusz Suchy, Krzysztof Łabuzek, Łukasz Bułdak, Dawid Szkudłapski, and Bogusław Okopień, “Comparison of chosen activation markers of human monocytes/macrophages isolated from the peripheral blood of young and elderly volunteers,” Pharmacological Reports, 2014. View at Publisher · View at Google Scholar
  • Ana Elisa Ferreira, Flavia Sisti, Fabiane Sonego, Suojuan Wang, Luciano Ribeiro Filgueiras, Stephanie Brandt, Ana Paula Moreira Serezani, Hong Du, Fernando Q. Cunha, Jose Carlos Alves-Filho, and Carlos Henrique Serezani, “PPAR-gamma/IL-10 Axis Inhibits MyD88 Expression and Ameliorates Murine Polymicrobial Sepsis,” Journal of Immunology, vol. 192, no. 5, pp. 2357–2365, 2014. View at Publisher · View at Google Scholar
  • Jerome Morel, and Mervyn Singer, “Statins, fibrates, thiazolidinediones and resveratrol as adjunctive therapies in sepsis: could mitochondria be a common target?,” Intensive care medicine experimental, vol. 2, no. 1, pp. 9, 2014. View at Publisher · View at Google Scholar
  • Xiao-Min Xin, Mu-Xiao Zhong, Gong-Li Yang, Yao Peng, Ya-Li Zhang, and Wei Zhu, “GW4064, a farnesoid X receptor agonist, upregulates adipokine expression in preadipocytes and HepG2 cells,” World Journal of Gastroenterology, vol. 20, no. 42, pp. 15727–15735, 2014. View at Publisher · View at Google Scholar
  • Nikhilesh Arya, Kishor S. Jain, Mangesh D. Kharjul, Vishnu N. Thakare, and Chamanlal J. Shishoo, “Some molecular targets for antihyperlipidemic drug research,” European Journal of Medicinal Chemistry, vol. 85, pp. 535–568, 2014. View at Publisher · View at Google Scholar
  • Guoda Ma, Haiyang Wang, Guixi Mo, Lili Cui, You Li, Yiming Shao, Xin Liu, Yuliu Xie, Jia Li, Jiawu Fu, Hua Tao, Bin Zhao, Liangqing Zhang, and Keshen Li, “ The Pro12Ala Polymorphism of PPAR- γ Gene Is Associated with Sepsis Disease Severity and Outcome in Chinese Han Population ,” PPAR Research, vol. 2014, pp. 1–8, 2014. View at Publisher · View at Google Scholar
  • Daniela Rovito, Cinzia Giordano, Pierluigi Plastina, Ines Barone, Francesca De Amicis, Loredana Mauro, Pietro Rizza, Marilena Lanzino, Stefania Catalano, Daniela Bonofiglio, and Sebastiano Andò, “Omega-3 DHA- and EPA-Dopamine Conjugates induce PPARγ-dependent breast cancer cell death through autophagy and apoptosis,” Biochimica et Biophysica Acta (BBA) - General Subjects, 2015. View at Publisher · View at Google Scholar
  • Makoto Miyoshi, Norihito Iizuka, Shota Sakai, Mayu Fujiwara, Michiko Aoyama-Ishikawa, Noriaki Maeshige, Yasuhiro Hamada, Michiko Takahashi, and Makoto Usami, “Oral tributyrin prevents endotoxin-induced lipid metabolism disorder,” Clinical Nutrition ESPEN, vol. 10, no. 2, pp. e83–e88, 2015. View at Publisher · View at Google Scholar
  • Ga Bin Park, Dae Young Hur, Yeong Seok Kim, Hyun-Kyung Lee, Jae Wook Yang, and Daejin Kim, “TLR3/TRIF signalling pathway regulates IL-32 and IFN-β secretion through activation of RIP-1 and TRAF in the human cornea,” Journal of Cellular and Molecular Medicine, 2015. View at Publisher · View at Google Scholar
  • Yuval Ramot, Arianna Mastrofrancesco, Emanuela Camera, Pierre Desreumaux, Ralf Paus, and Mauro Picardo, “ The role of PPAR γ -mediated signalling in skin biology and pathology: new targets and opportunities for clinical dermatology ,” Experimental Dermatology, vol. 24, no. 4, pp. 245–251, 2015. View at Publisher · View at Google Scholar
  • Min Xu, Ying-Zhou Tian, Xiu-Jun Zhu, Xi Zhang, Jing-Yan Zhu, Chun-Xiao Gu, Yi Chen, and Jian-Ling Huang, “Effect of Xianziyizhen Recipe Capsule on PGI2-PPARδ Signaling Pathway in Embryo Implantation Dysfunction Mice,” American Journal of Reproductive Immunology, 2015. View at Publisher · View at Google Scholar
  • Dong Hyeok Kim, Hyun-ju Ihn, Chaerin Moon, Sang-Seok Oh, Soojong Park, Suk Kim, Keun Woo Lee, and Kwang Dong Kim, “Ciglitazone, a Peroxisome Proliferator-Activated Receptor Gamma Ligand, Inhibits Proliferation and Differentiation of Th17 Cells,” Biomolecules & Therapeutics, vol. 23, no. 1, pp. 71–76, 2015. View at Publisher · View at Google Scholar
  • Luciane Alarcão Dias-Melicio, Reginaldo Keller Fernandes, Daniela Ramos Rodrigues, Marjorie Assis Golim, and Angela Maria Victoriano Campos Soares, “Interleukin-18 Increases TLR4 and Mannose Receptor Expression and Modulates Cytokine Production in Human Monocytes,” Mediators of Inflammation, vol. 2015, pp. 1–9, 2015. View at Publisher · View at Google Scholar
  • Youzhu Qiu, Jie Yang, Shizhu Bian, Guozhu Chen, and Jie Yu, “PPARγ suppresses the proliferation of cardiac myxoma cells through downregulation of MEF2D in a miR-122-dependent manner,” Biochemical and Biophysical Research Communications, 2016. View at Publisher · View at Google Scholar
  • Wei Huang, Peter Szatmary, Meihua Wan, Shameena Bharucha, Muhammad Awais, Wenfu Tang, David N. Criddle, Qing Xia, and Robert Sutton, “Translational Insights Into Peroxisome Proliferator-Activated Receptors in Experimental Acute Pancreatitis,” Pancreas, vol. 45, no. 2, pp. 167–178, 2016. View at Publisher · View at Google Scholar
  • Daniela Bonofiglio, Marilena Lanzino, Cinzia Giordano, Stefania Catalano, and Sebastiano Andò, “Omega-3 DHA and EPA Conjugates Trigger Autophagy Through PPARγ Activation in Human Breast Cancer Cells,” Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging, pp. 291–305, 2016. View at Publisher · View at Google Scholar
  • Daniela Rovito, Daniela Bonofiglio, Ines Barone, Cinzia Giordano, Fedora Grande, Stefania Catalano, Sebastiano Andò, Giulia Gionfriddo, Francesca De Amicis, and Marilena Lanzino, “Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression,” Oncotarget, vol. 7, no. 40, pp. 65109–65124, 2016. View at Publisher · View at Google Scholar
  • Aravind T. Reddy, Sowmya P. Lakshmi, and Raju C. Reddy, “ PPAR γ in Bacterial Infections: A Friend or Foe? ,” PPAR Research, vol. 2016, pp. 1–7, 2016. View at Publisher · View at Google Scholar
  • Qingqing Wang, Mustapha Umar Imam, Fudi Wang, and Zhang Yida, “Peroxisome proliferator-activated receptor gamma (PPARγ) as a target for concurrent management of diabetes and obesity-related cancer,” Current Pharmaceutical Design, vol. 23, no. 25, pp. 3677–3688, 2017. View at Publisher · View at Google Scholar
  • Motoki Kai, Makoto Miyoshi, Mayu Fujiwara, Yuya Nishiyama, Taketo Inoue, Noriaki Maeshige, Yasuhiro Hamada, and Makoto Usami, “A lard-rich high-fat diet increases hepatic peroxisome proliferator–activated receptors in endotoxemic rats,” Journal of Surgical Research, vol. 212, pp. 22–32, 2017. View at Publisher · View at Google Scholar
  • Mathieu Sertorio, Wei Du, Surya Amarachintha, Andrew Wilson, and Qishen Pang, “In Vivo RNAi Screen Unveils PPARγ as a Regulator of Hematopoietic Stem Cell Homeostasis,” Stem Cell Reports, 2017. View at Publisher · View at Google Scholar
  • Yoshimasa Taniguchi, Hiroyuki Nakayama, Yasuhisa Ano, Atsushi Dohata, Ayaka Hoshi, Kazuyuki Uchida, and Akihiko Takashima, “Iso-α-acids, bitter components of beer, prevent inflammation and cognitive decline induced in a mouse model of Alzheimer's disease,” Journal of Biological Chemistry, vol. 292, no. 9, pp. 3720–3728, 2017. View at Publisher · View at Google Scholar
  • Rabah M. Shawky, Tarek M. Kamal, Shaimaa Raafat, and Ghada H. El Nady, “Genotyping of PPAR-γ gene polymorphism in Egyptian neonates affected with sepsis disease and its severity,” Egyptian Journal of Medical Human Genetics, 2017. View at Publisher · View at Google Scholar
  • JunYing Guo, Chao Liu, Sheng Zhang, Weifeng Tang, Jiakai Jiang, Zhiqiang Xie, Yafeng Wang, and Yu Chen, “Association of PPARG rs 1801282 C > G polymorphism with risk of colorectal cancer: From a case-control study to a meta-analysis,” Oncotarget, vol. 8, no. 59, pp. 100558–100569, 2017. View at Publisher · View at Google Scholar
  • Sowmya P. Lakshmi, Aravind T. Reddy, Asoka Banno, and Raju C. Reddy, “PPAR Agonists for the Prevention and Treatment of Lung Cancer,” PPAR Research, vol. 2017, pp. 1–8, 2017. View at Publisher · View at Google Scholar
  • Takeshi Matsutani, Kazuhiro Tamura, Masahiko Kutsukake, Akihisa Matsuda, Eiichi Tachikawa, and Eiji Uchida, “Impact of Pioglitazone on Macrophage Dynamics in Adipose Tissues of Cecal Ligation and Puncture-Treated Mice,” Biological and Pharmaceutical Bulletin, vol. 40, no. 5, pp. 638–644, 2017. View at Publisher · View at Google Scholar
  • Lu Liu, Yilin Pan, Cui Zhai, Yanting Zhu, Rui Ke, Wenhua Shi, Jian Wang, Xin Yan, Xiaofan Su, Yang Song, Li Gao, and Manxiang Li, “Activation of peroxisome proliferation-activated receptor-γ inhibits transforming growth factor-β1-induced airway smooth muscle cell proliferation by suppressing Smad-miR-21 signaling,” Journal of Cellular Physiology, 2018. View at Publisher · View at Google Scholar
  • Biljana Pokimica, and María-Teresa García-Conesa, “Critical Evaluation of Gene Expression Changes in Human Tissues in Response to Supplementation with Dietary Bioactive Compounds: Moving Towards Better-Quality Studies,” Nutrients, vol. 10, no. 7, pp. 807, 2018. View at Publisher · View at Google Scholar
  • Yurong Wang, Yuan Xu, Pingping Zhang, Wenchen Ruan, Luyong Zhang, Shengtao Yuan, Tao Pang, and Ai-Qun Jia, “Smiglaside A ameliorates LPS-induced acute lung injury by modulating macrophage polarization via AMPK-PPARγ pathway,” Biochemical Pharmacology, vol. 156, pp. 385–395, 2018. View at Publisher · View at Google Scholar
  • Asoka Banno, Aravind T. Reddy, Sowmya P. Lakshmi, and Raju C. Reddy, “PPARs: Key Regulators of Airway Inflammation and Potential Therapeutic Targets in Asthma,” Nuclear Receptor Research, vol. 5, 2018. View at Publisher · View at Google Scholar